1) We’ve written a new article about the spectacular progress in artificial intelligence (AI), the billions that AI companies are investing to transform drug discovery, and why this is a reason for hope for ME/CFS patients.
Here's a brief summary 👇
mecfsscience.org/the-ai-revolut…
Here's a brief summary 👇
mecfsscience.org/the-ai-revolut…
8
8
43
1,679
14) None of this is meant to overlook the many downsides and dangers of AI, but ME/CFS patients are among the wretched of this earth, and they have the most to gain from a coming AI revolution!
1
0
3
187
15) Interested in hearing other people’s thoughts and ideas about this.
See also this thread and discussion on S4ME:
s4me.info/threads/achiev…
See also this thread and discussion on S4ME:
s4me.info/threads/achiev…
1
0
4
185
Suspect the same applies to the Horizon Europe programs.
Grant applications have become a lottery. A 60% growth in applications to one of the world’s most prestigious research-grant programs is resulting in an exceptionally low success rate
I think this is one of the major problems of AI--it's creating tsunami of grant applications n process into chaos.
Grant decisions already felt fairly random and this seems to make the system worse.
nature.com/articles/d4158…
0
0
10
489
ME/CFS Science retweeted
Grant applications have become a lottery. A 60% growth in applications to one of the world’s most prestigious research-grant programs is resulting in an exceptionally low success rate
I think this is one of the major problems of AI--it's creating tsunami of grant applications n process into chaos.
Grant decisions already felt fairly random and this seems to make the system worse.
nature.com/articles/d4158…
I think this is one of the major problems of AI--it's creating tsunami of grant applications n process into chaos.
Grant decisions already felt fairly random and this seems to make the system worse.
nature.com/articles/d4158…
9
48
197
22,571
1) It's been a while since we heard from the microclot theory.
This new paper from Oxford says it found no evidence of hypercoagulability, altered fibrinolysis, or increased microclots.
Important caveat: it used frozen samples and a different technique to measure clots.
This new paper from Oxford says it found no evidence of hypercoagulability, altered fibrinolysis, or increased microclots.
Important caveat: it used frozen samples and a different technique to measure clots.
7
9
72
2,366
9) The authors conclude that antithrombotic therapy for Long Covid is not justified outside of clinical trials. Their results were published as a brief letter in HemaSphere, journal of the European Hematology Association.
2
0
8
280
10) Link to the paper:
Fraser 2026. No evidence of hypercoagulability, altered fibrinolysis, or increased fibrin(ogen) microaggregates in never-hospitalized long COVID.
onlinelibrary.wiley.com/doi/10.1002/he…
Fraser 2026. No evidence of hypercoagulability, altered fibrinolysis, or increased fibrin(ogen) microaggregates in never-hospitalized long COVID.
onlinelibrary.wiley.com/doi/10.1002/he…
1
0
10
266